Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Human Cancers”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Early research (Phase 1)Study completedNCT02364492
What this trial is testing

A Phase I Study of a Therapeutic Vaccine Candidate in Patients With Localized Breast Cancer at High-Risk of Relapse

Who this might be right for
Breast Neoplasms
Institut Pasteur 20
Testing effectiveness (Phase 2)Ended earlyNCT00343187
What this trial is testing

A Phase II Study of ACZONE™ (Dapsone) Gel, 5% As a Treatment For Tarceva® (Erlotinib)Related Rash

Who this might be right for
RashNon-small-Cell Lung Cancer
Allergan 2
Early research (Phase 1)Looking for participantsNCT07156136
What this trial is testing

Study of IMC-P115C in Advanced PRAME-Positive Cancers

Who this might be right for
PRAME PositiveCancerHLA-A*02:01-positive
Immunocore Ltd 140
Early research (Phase 1)Temporarily pausedNCT04222309
What this trial is testing

Laparoscopically Harvested Omental Free Tissue Autograft to Bypass the Blood Brain Barrier (BBB) in Human Recurrent Glioblastoma Multiforme (rGBM)

Who this might be right for
GliomaGlioma, MalignantGlioblastoma+4 more
Northwell Health 10
Early research (Phase 1)WithdrawnNCT04054752
What this trial is testing

Vaccine Response With NT-I7

Who this might be right for
Breast CarcinomaColorectal AdenocarcinomaBladder Carcinoma
National Cancer Institute (NCI)
Large-scale testing (Phase 3)Study completedNCT04812509
What this trial is testing

Efficacy and Safety of MW032 and Xgeva® in Subjects With Bone Metastases From Solid Tumors

Who this might be right for
Bone Metastases
Mabwell (Shanghai) Bioscience Co., Ltd. 708
Testing effectiveness (Phase 2)Active Not RecruitingNCT06077877
What this trial is testing

Investigate the Safety, Tolerability, Pharmacokinetics (PK), and Preliminary Anticancer Activity of GSK4524101 Alone or With Niraparib in Participants With Solid Tumors

Who this might be right for
Neoplasms
GlaxoSmithKline 42
Not applicableNot Yet RecruitingNCT07790601
What this trial is testing

Swabs in Screening for HPV (SWISH)

Who this might be right for
Anal CancerHuman Papilloma Virus (HPV)
Kirby Institute 700
Post-approval studies (Phase 4)UnknownNCT01698177
What this trial is testing

Optimizing Influenza Vaccination in Surgical Oncology Patients

Who this might be right for
Influenza
Stony Brook University 204
Early research (Phase 1)Study completedNCT03157167
What this trial is testing

An Evaluation of Tc 99m Tilmanocept by Intravenous (IV) and Subcutaneous (SC) Injection in Kaposi Sarcoma (KS)

Who this might be right for
Kaposi SarcomaHIV Infections
Navidea Biopharmaceuticals 15
Not applicableStudy completedNCT01135875
What this trial is testing

Laboratory Study of Early Tumor Markers in the Peripheral Blood of Glioblastoma Multiforme Patients

Who this might be right for
Glioblastoma MultiformeHealthy Volunteers
University of Florida 130
Testing effectiveness (Phase 2)Study completedNCT00002501
What this trial is testing

Cyclophosphamide and Filgrastim in Treating Patients With Stage IV, Relapsed, or Refractory Low-Grade Follicular Non-Hodgkin's Lymphoma

Who this might be right for
Lymphoma
Alliance for Clinical Trials in Oncology 29
Testing effectiveness (Phase 2)Study completedNCT01617629
What this trial is testing

Ovarian Cancer Vaccine for Patients Who Have Progressed During the CAN-003 Study

Who this might be right for
Epithelial Ovarian Cancer
Prima BioMed Ltd 9
Very early researchWithdrawnNCT03295695
What this trial is testing

PET-CT Imaging Using FDG-labeled Human Erythrocytes in Breast Cancer Patient

Who this might be right for
Breast CancerBreast Cancer, FemaleBreast Cancer, Male+1 more
H. Lee Moffitt Cancer Center and Research Institute
Early research (Phase 1)Study completedNCT04252339
What this trial is testing

RLY-1971 in Subjects With Advanced or Metastatic Solid Tumors

Who this might be right for
Solid Tumor, Unspecified, Adult
Hoffmann-La Roche 56
Testing effectiveness (Phase 2)Study completedNCT04260529
What this trial is testing

CyPep-1 Injections in Cancer Inducing Lymphocyte Infiltrate Accumulations

Who this might be right for
Advanced Solid Tumor Malignancy
Cytovation AS 60
Early research (Phase 1)Active Not RecruitingNCT05489237
What this trial is testing

First-in-human Study of IDRX-42 in Participants With Metastatic and/or Unresectable Gastrointestinal Stromal Tumors

Who this might be right for
Gastrointestinal NeoplasmsGastrointestinal Stromal Tumor (GIST)Digestive System Disease+2 more
IDRX, Inc., a wholly owned subsidiary of GSK, LLC 276
Testing effectiveness (Phase 2)Looking for participantsNCT05684965
What this trial is testing

XTX301 in Patients With Advanced Solid Tumors

Who this might be right for
Advanced Solid Tumor
Xilio Development, Inc. 358
Large-scale testing (Phase 3)Active Not RecruitingNCT03654053
What this trial is testing

Multi-Center Study of the Effects of Simvastatin on Hepatic Decompensation and Death in Subjects Presenting With High-Risk Compensated Cirrhosis

Who this might be right for
Cirrhosis
VA Office of Research and Development 142
Early research (Phase 1)Ended earlyNCT02151357
What this trial is testing

Safety, Tolerability and Pharmacokinetics of DCBCI0901 in Patients With Advanced Solid Tumor

Who this might be right for
Cancer
Standard Chem. & Pharm. Co., Ltd. 17
Next Page